Discover high-confidence drug targets faster with AI-powered biological insights.
Zekai Verdict
- What is it?
- Standigm ASK leverages AI and knowledge graphs to accelerate novel therapeutic target identification and prioritization for pharmaceutical R&D.
- Best for
- Computational biologists and drug discovery scientists benefit most from Standigm ASK. Its ability to process and…
- Price
- Pricing on request
- Zekai Score
- 6.7/10
Schrödinger
Insilico Medicine
Blank Bio
Recursion
AbCellera
B‑12 Labs
ExscientiaFor pharmaceutical and biotech R&D, Standigm is a leading AI solution for accelerating drug discovery. Its Standigm ASK platform uses proprietary AI and knowledge graphs to analyze vast biological datasets, effectively identifying and prioritizing novel therapeutic targets. This approach significantly reduces the time and failure rates common in early-stage research, enabling teams to build more efficient and successful development pipelines.
Try it with these prompts
Copy any prompt and paste it directly into the tool.
Analyze the provided dataset to identify novel drug targets for [disease area]. Focus on targets with potential for first-in-class therapies based on [specific biological pathways or mechanisms].
Optimize the lead compound [compound name] to meet diverse properties such as [desired property 1] and [desired property 2]. Suggest modifications to improve efficacy and reduce toxicity.
Generate 1,000 new molecule ideas for the target [target name] within 1 week. Ensure the generated molecules have potential for [specific application or therapeutic area].
Prompts for Pharma
Trusted by professionals
Best Standigm alternatives
Standigm vs. BenevolentAI: While both platforms leverage AI and knowledge graphs for drug discovery, they exhibit different areas of emphasis. Standigm, particularly with its ASK platform, specializes in the early, critical stage of identifying and prioritizing novel therapeutic targets by integrating diverse biological datasets. This provides a focused solution for R&D teams looking to optimize the very beginning of their pipeline. BenevolentAI offers a more end-to-end platform, applying its AI from early discovery through to clinical development. For teams needing a highly specialized tool to de-risk and accelerate target identification specifically, Standigm's focused approach may offer a more direct advantage.
Is Standigm worth it?
Why Pharmaceutical & Biotech choose this tool
Key Use Cases
Frequently asked questions
Does Standigm ASK offer a free trial?
What is the best use of Standigm ASK for Pharmaceutical R&D?
Does Standigm ASK integrate with existing R&D platforms?
How does Standigm ASK provide value for money?
Standigm pricing and plans
Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.
Top 10 AI tools in this category
Take it with you
- The challenge of traditional R&D
- How AI is changing the landscape
- Company overview
- Core Technology: The Standigm ASK™ AI Platform
- How It Works: Knowledge Graphs & Data Integration
Get Standigm ASK deal alerts
Be the first to know when Standigm ASK drops a new discount, adds features, or changes pricing.
More on AI for Pharmaceutical & Biotech
- Telehealth Access Trends: What Pharma Professionals Need to Know
- Leqembi’s Sales Forecast Signals New Diagnostic Frontiers for Pharma Professionals
- Roche’s ctDNA Approval: A New Era for Pharma Professionals
- AI for Drug Discovery: A Step-by-Step Guide (2026)
- 25 AI Prompts for Pharmaceutical Researchers (2026)
Latest AI news
About Standigm ASK
Full Description
Standigm ASK leverages AI and knowledge graphs to accelerate novel therapeutic target identification and prioritization for pharmaceutical R&D. It integrates diverse biological datasets to pinpoint promising drug discovery avenues, reducing time and failure rates in early-stage research. This platform empowers R&D teams to make data-driven decisions for more efficient drug development pipelines.
